logo
Plus   Neg
Share
Email

Axel Springer To Delist On April 6 From Frankfurt Stock Exchange - Quick Facts

German media holding company Axel Springer SE (AXELF.PK) announced Wednesday that the Frankfurt Stock Exchange has informed that its delisting application has been approved. The Axel Springer SE shares will be delisted from the regulated market of the Frankfurt Stock Exchange in accordance with the stock exchange regulations at the end of April 6, 2020.

Thereafter, the Axel Springer SE shares can no longer be traded on the Frankfurt Stock Exchange after being a listed company for a 35-year period.

Axel Springer SE assumes that the stock exchanges in Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart as well as Tradegate Exchange will end the inclusion of the Axel Springer SE shares in the open market likely in close temporal proximity with the delisting from the Frankfurt Stock Exchange.

Heralding a new phase of growth after departure from the stock market, Axel Springer said it will focus all its attention on its ambitious goal of becoming the world market leader in digital journalism and digital classifieds along with its strategic partner KKR (KKR). It added that the newly won freedom will be used to systematically implement and accelerate the strategy of growth and investments.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased. Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Palantir Technologies Inc., the Silicon Valley big data analytics company that has handled U.S. government's certain sensitive projects, said it has confidentially filed documents with the Securities and Exchange Commission to go public. In a statement, the company said the proposed public listing of its Class A common stock is expected to take place after the SEC completes its review process.
Follow RTT